Stockreport

Join OS Therapies’ Exclusive Live Investor Webinar and Q&A Session on October 30

OS Therapies Incorporated  (OSTX) 
PDF NEW YORK--(BUSINESS WIRE)--OS Therapies (NYSE American: OSTX) (“OS Therapies” or “the Company”), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) bio [Read more]